Difference between revisions of "Part:BBa K4789002"
Sunny Duan (Talk | contribs) |
Sunny Duan (Talk | contribs) |
||
| Line 12: | Line 12: | ||
[3]Zhang Lu,Chen Bin,Ding Ding,Decreased microRNA-22 is associated with poor prognosis in cervical cancer.[J] .Int J Clin Exp Pathol, 2017, 10: 9515-9520. | [3]Zhang Lu,Chen Bin,Ding Ding,Decreased microRNA-22 is associated with poor prognosis in cervical cancer.[J] .Int J Clin Exp Pathol, 2017, 10: 9515-9520. | ||
| − | |||
Revision as of 08:26, 6 October 2023
pre-miR-22
A growing number of studies highlights the role of miR-22 in cervical cancer drug resistance development [1-3]. Pre-miR-22 basic part was used to overexpress miR-22 in Hela cells.
Reference
[1] Nejati Kazem,Alivand MohammadReza,Arabzadeh AmirAhmad,MicroRNA-22 in female malignancies: Focusing on breast, cervical, and ovarian cancers.[J] .Pathol Res Pract, 2021, 223: 153452.
[2]Konishi Hiromi,Hayashi Masami,Taniguchi Kohei et al. The therapeutic potential of exosomal miR-22 for cervical cancer radiotherapy.[J] .Cancer Biol Ther, 2020, 21: 1128-1135.
[3]Zhang Lu,Chen Bin,Ding Ding,Decreased microRNA-22 is associated with poor prognosis in cervical cancer.[J] .Int J Clin Exp Pathol, 2017, 10: 9515-9520.